Autoimmune Disease News and Research

RSS

Autoimmune Disease is a condition in which the body recognizes its own tissues as foreign and directs an immune response against them.

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.

10 Oct 2013

Key findings may have broad implications for future scleroderma therapy

The Scleroderma Research Foundation today said that researchers at The Johns Hopkins University working in a novel mouse model of Stiff Skin Syndrome have made key discoveries that may have broad implications for future scleroderma therapy.

10 Oct 2013

Scientists at Oklahoma Medical Research Foundation identify six new Sj-gren-related genes

With the completion of the first genome-wide association study for Sj-gren's syndrome, an international coalition of researchers led by scientists at the Oklahoma Medical Research Foundation has identified six new disease-related genes.

7 Oct 2013

J&J's Janssen Companies Launch A Trio Of Collaborations

...

3 Oct 2013

New classification criteria for systemic sclerosis published in ACR journal

New classification criteria for systemic sclerosis have just been published and are more sensitive than the 1980 criteria, enabling earlier identification and treatment of this disabling autoimmune disease.

3 Oct 2013

Biochemists discover promising vitamin D-based treatment that halts or reverse MS

A diagnosis of multiple sclerosis (MS) is a hard lot. Patients typically get the diagnosis around age 30 after experiencing a series of neurological problems such as blurry vision, wobbly gait or a numb foot. From there, this neurodegenerative disease follows an unforgiving course.

1 Oct 2013

Pfizer Licenses Gliknik's Pooled IVIG In $25M+ Deal

...

30 Sep 2013

Discovery provides additional key insights into the biology of Multiple Sclerosis

A Griffith University medical scientist is part of an international team which has made a key discovery in the effort to find the cause and cure of Multiple Sclerosis.

30 Sep 2013

Biochemists discover promising vitamin D-based treatment that can halt MS

A diagnosis of multiple sclerosis is a hard lot. Patients typically get the diagnosis around age 30 after experiencing a series of neurological problems such as blurry vision, wobbly gait or a numb foot. From there, this neurodegenerative disease follows an unforgiving course.

29 Sep 2013

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

The prevalence of skin disease exceeds that of obesity, hypertension or cancer. One in three individuals in the United States suffers with a skin disease, with ~2-3% of the American population suffering from psoriasis.

27 Sep 2013

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes & Endocrinology.

24 Sep 2013

Researchers develop first imaging tool to examine myelin damage in MS

Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.

24 Sep 2013

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis.

23 Sep 2013

Researchers discover new mechanism involving p53 to fight against aggressive cancers

Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers.

20 Sep 2013

Mitsubishi Tanabe Pharma acquires Medicago

Mitsubishi Tanabe Pharma Corporation and Medicago Inc. announced today the completion of the previously announced acquisition of Medicago Inc. by MTPC.

18 Sep 2013

Immune marker predicts transplant success, improves selection of bone marrow donors

The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.

17 Sep 2013

Understanding essential role of gut microbes in immune system

A new understanding of the essential role of gut microbes in the immune system may hold the key to dealing with some of the more significant health problems facing people in the world today, Oregon State University researchers say in a new analysis.

17 Sep 2013

Vanderbilt examines ability of drug abatacept to prevent type 1 diabetes

Vanderbilt's Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

17 Sep 2013

Becker's Hospital Review names Virginia Mason as one of 50 Greenest Hospitals in America

Virginia Mason has been named one of the 50 Greenest Hospitals in America for 2013 by Becker's Hospital Review, a leading health care publication.

12 Sep 2013

Parent's guide book for caring children living with juvenile arthritis

Parents who have children with chronic autoimmune diseases like juvenile arthritis face a lifetime of obstacles and challenges and now there's a book to help them. In Living with Juvenile Arthritis: A Parent's Guide, author Kimberly Poston Miller shares with readers her hard-earned wisdom and experiences as the mother of two children living with juvenile arthritis and a number of related autoimmune conditions.

11 Sep 2013

Autoimmune Disease News and Research

Further Reading

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Key findings may have broad implications for future scleroderma therapy

Scientists at Oklahoma Medical Research Foundation identify six new Sj-gren-related genes

J&J's Janssen Companies Launch A Trio Of Collaborations

New classification criteria for systemic sclerosis published in ACR journal

Biochemists discover promising vitamin D-based treatment that halts or reverse MS

Pfizer Licenses Gliknik's Pooled IVIG In $25M+ Deal

Discovery provides additional key insights into the biology of Multiple Sclerosis

Biochemists discover promising vitamin D-based treatment that can halt MS

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

Researchers develop first imaging tool to examine myelin damage in MS

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Researchers discover new mechanism involving p53 to fight against aggressive cancers

Mitsubishi Tanabe Pharma acquires Medicago

Immune marker predicts transplant success, improves selection of bone marrow donors

Understanding essential role of gut microbes in immune system

Vanderbilt examines ability of drug abatacept to prevent type 1 diabetes

Becker's Hospital Review names Virginia Mason as one of 50 Greenest Hospitals in America

Parent's guide book for caring children living with juvenile arthritis

Understanding the DNA Damage Response in Innate Immunity eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News